CreativeOne Wealth LLC increased its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 19.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,681 shares of the semiconductor company’s stock after purchasing an additional 431 shares during the period. CreativeOne Wealth LLC’s holdings in Synopsys were worth $1,301,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in SNPS. Kieckhefer Group LLC bought a new position in shares of Synopsys during the 4th quarter valued at $27,000. Whipplewood Advisors LLC purchased a new stake in Synopsys during the fourth quarter valued at $33,000. Pilgrim Partners Asia Pte Ltd bought a new position in Synopsys in the fourth quarter valued at about $34,000. Sierra Ocean LLC purchased a new position in Synopsys in the fourth quarter worth about $39,000. Finally, Hazlett Burt & Watson Inc. grew its stake in shares of Synopsys by 28.6% during the 4th quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company’s stock valued at $44,000 after purchasing an additional 20 shares during the period. Institutional investors own 85.47% of the company’s stock.
Insider Activity
In other Synopsys news, CEO Sassine Ghazi sold 11,366 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the completion of the transaction, the chief executive officer now owns 70,922 shares in the company, valued at $32,890,077.50. This trade represents a 13.81 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Geus Aart De sold 15,705 shares of the company’s stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $444.42, for a total value of $6,979,616.10. Following the sale, the insider now directly owns 116,671 shares in the company, valued at $51,850,925.82. This trade represents a 11.86 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.62% of the company’s stock.
Analyst Upgrades and Downgrades
Read Our Latest Report on Synopsys
Synopsys Trading Down 2.3 %
Shares of SNPS opened at $415.65 on Thursday. The business’s 50 day moving average is $451.03 and its 200 day moving average is $496.32. Synopsys, Inc. has a 12-month low of $365.74 and a 12-month high of $624.80. The company has a market capitalization of $64.27 billion, a PE ratio of 28.63, a price-to-earnings-growth ratio of 3.23 and a beta of 1.23.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Stories
- Five stocks we like better than Synopsys
- Ride Out The Recession With These Dividend Kings
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- Trading Stocks: RSI and Why it’s Useful
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- How to Short Nasdaq: An Easy-to-Follow Guide
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.